This site is intended for healthcare professionals only
LoginRegister

Diabetes and Endocrinology Dialogues

Tirzepatide may reduce CVD Risk in Non-Diabetic Overweight Patients

Tirzepatide may reduce CVD Risk in Non-Diabetic Overweight Patients

The outcomes from the SURMOUNT-1 phase 3 trial found tirzepatide to effectively manage the long-term risk of atherosclerotic cardiovascular disease...
View All

Latest News and Guidelines

Standards of Care in Diabetes 2024: ADA recommends more personalization, additional obesity measurements beyond BMI

Standards of Care in Diabetes 2024: ADA recommends more personalization, additional obesity...

Higher HbA1c levels in early pregnancy without diabetes tied to increased risk of spontaneous pregnancy loss: Study

Higher HbA1c levels in early pregnancy without diabetes tied to increased risk of spontaneous...

Targeting TyG index more effective for primary and secondary prevention of hypertension, study suggests

Targeting TyG index more effective for primary and secondary prevention of hypertension, study...

Body dissatisfaction in late childhood tied to risk of depression by age 14: Lancet

Body dissatisfaction in late childhood tied to risk of depression by age 14: Lancet

Epigenetic alterations can cause type 2 diabetes, claims study

Epigenetic alterations can cause type 2 diabetes, claims study

Stricter cough syrup regulations imposed in Telangana following fatalities

Urinary endocrine-disrupting chemicals do not increase risk of metabolic syndrome among women

View All
X